GSK statement on tender offer to acquire Human Genome Sciences
18 May 2012 | By GlaxoSmithKline
GSK believes its offer represents full and fair value and is in the best interests of both companies’ shareholders...
List view / Grid view
18 May 2012 | By GlaxoSmithKline
GSK believes its offer represents full and fair value and is in the best interests of both companies’ shareholders...
15 December 2011 | By GlaxoSmithKline
Study to enrol over 800 adult patients with systemic lupus erythematosus...
20 May 2011 | By GlaxoSmithKline
The CHMP has issued a positive opinion, recommending marketing authorisation for Benlysta® (belimumab)...